Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lieberman

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Delaware Medical Journal|February 24, 2001
Voluntary Initiative Program IIJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1996
Compliance issues in primary careJ A Lieberman
Hospital Practice (1995)|July 15, 1997
Recognizing depression in primary care patientsJ A Lieberman
The Journal of Clinical Psychiatry|April 16, 1998
Maximizing clozapine therapy: managing side effectsJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1996
Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesisJ A Lieberman
The Journal of Clinical Psychiatry|March 1, 1993
Prediction of outcome in first-episode schizophreniaJ A Lieberman
Biological Psychiatry|October 6, 1999
Schizophrenia: comments on genes, development, risk factors, phenotype, and courseJ A Lieberman
Delaware Medical Journal|January 5, 2002
History of the Voluntary Initiative ProgramJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1997
BATHE: an approach to the interview process in the primary care settingJ A Lieberman
Biological Psychiatry|September 24, 1999
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspectiveJ A Lieberman
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Delaware Medical Journal|February 24, 2001
Voluntary Initiative Program IIJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1996
Compliance issues in primary careJ A Lieberman
Hospital Practice (1995)|July 15, 1997
Recognizing depression in primary care patientsJ A Lieberman
The Journal of Clinical Psychiatry|April 16, 1998
Maximizing clozapine therapy: managing side effectsJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1996
Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesisJ A Lieberman
The Journal of Clinical Psychiatry|March 1, 1993
Prediction of outcome in first-episode schizophreniaJ A Lieberman
Biological Psychiatry|October 6, 1999
Schizophrenia: comments on genes, development, risk factors, phenotype, and courseJ A Lieberman
Delaware Medical Journal|January 5, 2002
History of the Voluntary Initiative ProgramJ A Lieberman
The Journal of Clinical Psychiatry|January 1, 1997
BATHE: an approach to the interview process in the primary care settingJ A Lieberman
Biological Psychiatry|September 24, 1999
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspectiveJ A Lieberman
Pageof 25